Consensus Conference on Hypogonadism and TRT
Hypogonadism is a highly prevalent medical condition with significant impact and consequences on men’s health. However, it remains significantly under-diagnosed and under-treated. There are a number of barriers to recognition, diagnosis and treatment. These barriers include among other things the lack of specificity of symptoms, variability in laboratory testing and the uncertainty of the advantages and disadvantages of the various treatment options of Testosterone Replacement Theory (TRT).
Need for consensus
There is a substantial need for consensus on best practice statements for primary care practitioners and specialists alike. In response to this need, the International Society of Men’s Health organised the 2-day Consensus Conference on best practice in Hypogonadism and Testosterone Replacement Therapy in New York City from May 1 to May 2, 2010. A multidisciplinary international panel of experts served as faculty. The goal of the conference was to produce best practice statements for primary care practitioners and specialists. The conference was multi-sponsored.
A Planning meeting for the 2010 Consensus Conference on best practice in Hypogonadism and Testosterone Replacement Therapy was held in Vienna on October 8, 2009. The ISMH will publish the best practice statements in peer-reviewed journals. The publications will include 4 papers:
- A primary paper for the General Practice to be published in a general medicine journal
- An expanded version of the primary paper with specific issues relevant to urology such as prostate health, including case studies, to be published in a urology journal
- An expanded version of the primary paper with specific issues that relevant to endocrinology such as diabetes and the metabolic syndrome, be published in an endocrinology journal
- A forth paper will be published in the journal of men’s health (JOMH), the official journal of the ISMH. This paper will address knowledge gaps and propose future research
In addition, the International Society of Men’s Health will develop an educational website and web dissemination strategy that will guide the reader to the information contained in the various papers, other educational information on hypogonadism, TRT and discussions important to men’s health.